Cargando…
Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients
AIM: This study aims to evaluate plasma osteopontin (OPN) levels as a potential biomarker for hepatocellular carcinoma (HCC). BACKGROUND: Osteopontin (OPN) is a secreted glycoprotein that is associated with tumorigenesis and metastasis. METHODS: We measured plasma levels of OPN in 26 HCC patients, 2...
Autores principales: | Al-Zoubi, Sara, Wassouf, Ahmad, Zetoune, Almoutassem Billah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495895/ https://www.ncbi.nlm.nih.gov/pubmed/28702132 |
Ejemplares similares
-
Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes
por: Jaaban, Marwa, et al.
Publicado: (2021) -
Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
por: Hodeib, Hossam, et al.
Publicado: (2017) -
Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma
por: Salem, Mona, et al.
Publicado: (2013) -
Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma
por: Fouad, Shawky Abdelhamid, et al.
Publicado: (2015) -
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)